Qureight Appoints Craig Rhodes As Head Of Partnerships To Lead On Pharma Relationship Management

Qureight, a techbio institution advancing nan knowing of lung and bosom illness done exertion of its AI-powered imaging and objective information curation platform, coming announced nan assignment of Craig Rhodes arsenic Head of Partnerships to lead strategical engagements pinch pharmaceutical organizations, successful statement pinch Qureight’s gross maturation targets. Craig was formerly EMEA Director of Healthcare and Life Sciences astatine NVIDIA.

In his caller role, Craig will lead connected securing and managing strategical relationships pinch pharma partner organizations, from conception done to delivery. Leveraging his heavy expertise successful exertion integration and narration development, Craig will support nan take and integration of nan Qureight level into objective proceedings workflows. Qureight’s deep-learning image study and AI-powered information analytics level enables existent insights to beryllium drawn from analyzable and divers wellness data, including CT scans, physiological information and blood-based biomarkers to accelerate supplier improvement and heighten outcomes for patients pinch lung and bosom diseases, wherever location is precocious unmet aesculapian need.

A highly knowledgeable leader successful AI crossed some large tech and nan startup ecosystem, Craig has complete 25 years of acquisition and a proven way grounds of driving invention and translator crossed nan sector. In his domiciled astatine NVIDIA, Craig’s activity was instrumental to nan accelerated take of AI successful healthcare and supplier discovery, notably done nan cognition of Cambridge-1, nan UK’s largest AI supercomputer. This inaugural enabled groundbreaking investigation and group a caller benchmark for GPU-powered workloads successful life sciences, pinch partners including GSK, AstraZeneca, King’s College London, Guy’s and St Thomas’ Hospital, and Oxford Nanopore. Craig joins Qureight from deepc, wherever he spearheaded strategical collaborations pinch nan NHS to merge AI imaging models into objective workflows. Prior to his tenure astatine deepc, Craig played captious roles successful driving pathology and genomics AI initiatives astatine Intel, processing nationalist healthcare systems astatine Oracle, and contributing to objective pathway creation for nan NHS astatine nan Map of Medicine.

Craig’s background, expertise and web will beryllium invaluable successful driving our strategy to build and fortify our web of pharma partners to summation commercialized worth for nan company. Welcoming Craig to nan squad is simply a cardinal portion of our ongoing ngo to beforehand nan knowing of lung and bosom disease, revolutionize objective tests and accelerate supplier improvement done nan integration of our AI-powered solutions.”

Muhunthan Thillai, MD, Co-founder and CEO, Qureight

Craig Rhodes, Head of Partnerships, Qureight, added: “The clip it takes to walk a caller supplier done objective tests tin create a important bottleneck successful nan supplier improvement process, stalling nan support of caller therapies pinch life-changing potential. Qureight has created an impactful solution to reside this—an AI-powered imaging and objective information curation level that is already importantly enhancing supplier improvement done supporting faster, much businesslike objective trials. I’m excited to beryllium joining nan squad to support nan Company’s maturation and thief thrust its committedness to leveraging exertion to amended healthcare outcomes.”